Literature DB >> 7845366

Acetoacetate metabolism in AS-30D hepatoma cells.

D A Briscoe1, G Fiskum, A L Holleran, J K Kelleher.   

Abstract

Metabolic characteristics of experimental hepatoma cells include elevated rates of glycolysis and lipid synthesis. However, pyruvate derived from glucose is not redily oxidized, and the source of acetyl CoA for lipid synthesis in As-39D cells has not been characterized. In this study ketone bodies were examined as a possible source of acetyl CoA in AS-30D hepatoma cells. The major findings were: 1. Acetoacetate was utilized by AS-30D cells, with 14C-lipid and 14CO2 as major products of [3-14C] acetoacetate. 2. Lipid synthesis from acetoacetate was dependent on the presence of glucose in the medium. 3. Acetoacetate supported rapid respiration by AS-30D mitochondria in the presence of 0.1 mM malate. 4. Succinyl CoA acetoacetyl CoA transferase activity in AS-30D mitochondria was approximately 40 fold greater than that found in rat liver mitochondria. 5. Addition of acetoacetate, but not beta-hydroxybutyrate decreased conversion of [1-14C] acetate to 14CO2, presumably by diluting the specific radioactivity of the acetyl CoA derived from the acetate tracer. 6. In the presence of glucose, approximately one fourth of acetoacetate utilized was converted to lipid. This result is consistent with elevated lipogenesis postulated by the truncated TCA cycle hypothesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7845366     DOI: 10.1007/bf00926073

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  Continuous pyruvate carbon flux to newly synthesized cholesterol and the suppressed evolution of pyruvate-generated CO2 in tumors: further evidence for a persistent truncated Krebs cycle in hepatomas.

Authors:  R A Parlo; P S Coleman
Journal:  Biochim Biophys Acta       Date:  1986-04-29

2.  Establishment of a transplantable ascites variant of a rat hepatoma induced by 3'-methyl-4-dimethylaminoazobenzene.

Authors:  D F Smith; E F Walborg; J P Chang
Journal:  Cancer Res       Date:  1970-09       Impact factor: 12.701

3.  Beta-hydroxybutyrate dehydrogenase activity in liver and liver tumors.

Authors:  K Ohe; H P Morris; S Weinhouse
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

Review 4.  Membrane cholesterol, tumorigenesis, and the biochemical phenotype of neoplasia.

Authors:  P S Coleman; B B Lavietes
Journal:  CRC Crit Rev Biochem       Date:  1981

5.  Role of acetoacetyl-CoA synthetase in acetoacetate utilization by tumor cells.

Authors:  M J Tisdale
Journal:  Cancer Biochem Biophys       Date:  1984-06

6.  Isolation of mitochondria from ascites tumor cells permeabilized with digitonin.

Authors:  R W Moreadith; G Fiskum
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365

7.  Stimulation of tumor growth in adult rats in vivo during an acute fast.

Authors:  L A Sauer; W O Nagel; R T Dauchy; L A Miceli; J E Austin
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

8.  Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells.

Authors:  R A Nakashima; M G Paggi; P L Pedersen
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

9.  Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism.

Authors:  K C Fearon; W Borland; T Preston; M J Tisdale; A Shenkin; K C Calman
Journal:  Am J Clin Nutr       Date:  1988-01       Impact factor: 7.045

10.  Analysis of tricarboxylic acid-cycle metabolism of hepatoma cells by comparison of 14CO2 ratios.

Authors:  J K Kelleher; B M Bryan; R T Mallet; A L Holleran; A N Murphy; G Fiskum
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

View more
  1 in total

1.  Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity.

Authors:  Tianxiao Yang; Yilin Wang; Wenjuan Dai; Xixi Zheng; Jing Wang; Shushu Song; Lan Fang; Jiangfan Zhou; Weicheng Wu; Jianxin Gu
Journal:  J Hematol Oncol       Date:  2018-04-04       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.